Dr. Isaac Laurence Kelly, MD

Dr. Kelly practices at Inland Urology Medical Group Inc in Upland, California.

Dr. Kelly's NPI, 1083057525, was assigned on April 15, 2013. Dr. Kelly graduated from Loma Linda University School Of Medicine in 2013. Dr. Kelly holds California license A134284.

Dr. Kelly's primary practice is Inland Urology Medical Group Inc, at 1113 Alta Ave, Upland, CA 91786 in San Bernardino County. The practice phone is (909) 623-3428.

Dr. Kelly's primary practice is Inland Urology Medical Group Inc in Upland, California. Dr. Kelly is also affiliated with San Antonio Regional Hospital. The medical group on file is Inland Urology Medical Group, Inc. Dmand AI also links Dr. Kelly to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kelly practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kelly's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kelly is board certified in urology by the American Board of Urology. Dr. Kelly is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Kelly treats.

CMS data shows 1,303 Medicare services from Dr. Kelly across 12 procedure codes in 2024, for 499 Medicare patients. Medicare paid $113,657 for them.

CMS counts 499 Medicare patients who saw Dr. Kelly in 2024. The largest group is 65 to 74, with 215 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kelly's median patient age at 67, with 32% women.

In 2024, Dr. Kelly wrote 1,825 Medicare Part D claims for 532 patients. 86% of them were for generic drugs. CMS names the drug for 1,645 of them, across 22 drugs with 11 or more claims each, at $567,461 in total drug cost. In 2023, CMS named 1,417 claims across 22 drugs.

Dr. Kelly accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kelly as offering telehealth. CMS counts 15 procedures of prostate resection by Dr. Kelly, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Kelly, published from 2017 to 2018. 2018 was the busiest year, with 3. Dr. Kelly's most frequent co-authors are Andrea Staack, MD, Junchan Joshua Yune, MD and Samuel Abourbih, CM, MD.

CMS Open Payments shows 260 general payments to Dr. Kelly from 49 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 71% of the total. Boston Scientific Corporation paid the most, $1,626.

Dr. Kelly graduated from Loma Linda University School Of Medicine in 2013.

Dr. Kelly is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.